Regulus Therapeutics Inc.

NasdaqCM:RGLS Rapporto sulle azioni

Cap. di mercato: US$105.4m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Regulus Therapeutics Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Regulus Therapeutics has a total shareholder equity of $98.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $104.1M and $5.9M respectively.

Informazioni chiave

0%

Rapporto debito/patrimonio netto

US$0

Debito

Indice di copertura degli interessin/a
ContantiUS$94.46m
Patrimonio nettoUS$98.18m
Totale passivitàUS$5.94m
Totale attivitàUS$104.12m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Regulus surges 15% after Phase 1 data for kidney disease candidate

Sep 12

Regulus Therapeutics GAAP loss per share narrows

Aug 11

Does Regulus Therapeutics (NASDAQ:RGLS) Have A Healthy Balance Sheet?

Oct 12
Does Regulus Therapeutics (NASDAQ:RGLS) Have A Healthy Balance Sheet?

The Read On Regulus Therapeutics

Aug 03

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Regulus Therapeutics Inc.'s (NASDAQ:RGLS) CEO For Now

Jun 09
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Regulus Therapeutics Inc.'s (NASDAQ:RGLS) CEO For Now

Regulus reports top-line data from early-stage RGLS4326 trial in polycystic kidney disease

May 03

Auditors Are Concerned About Regulus Therapeutics (NASDAQ:RGLS)

Mar 13
Auditors Are Concerned About Regulus Therapeutics (NASDAQ:RGLS)

Introducing Regulus Therapeutics (NASDAQ:RGLS), The Stock That Zoomed 101% In The Last Year

Mar 10
Introducing Regulus Therapeutics (NASDAQ:RGLS), The Stock That Zoomed 101% In The Last Year

Regulus Therapeutics announces closing of $19.4M private placement

Dec 08

Regulus Therapeutics EPS beats by $0.17, beats on revenue

Nov 05

Analisi della posizione finanziaria

Passività a breve termine: RGLS's short term assets ($100.3M) exceed its short term liabilities ($5.3M).

Passività a lungo termine: RGLS's short term assets ($100.3M) exceed its long term liabilities ($675.0K).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: RGLS is debt free.

Riduzione del debito: RGLS has no debt compared to 5 years ago when its debt to equity ratio was 308.3%.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: RGLS has sufficient cash runway for more than a year based on its current free cash flow.

Previsione Cash Runway: RGLS has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 5.3% each year.


Scoprire le aziende sane